Joachim Feldwisch

发表

Advancing molecular-guided surgery through probe development and testing in a moderate cost evaluation pipeline

Brian W Pogue, Keith D Paulsen, Jack Hoopes, 2015, Photonics West - Biomedical Optics.

EGFR-directed Affibody for fluorescence-guided glioma surgery: time-dose analysis (Conference Presentation)

Jason R. Gunn, Keith D. Paulsen, Jonathan T. Elliott, 2016, SPIE BiOS.

Perspectives on the phase 0 clinical trial of microdose administration of ABY-029 for fluorescence guided surgery: stability testing

Keith Paulsen, Brian W. Pogue, David Roberts, 2020, BiOS.

Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection

Keith Paulsen, Brian Pogue, Jason Gunn, 2019, BiOS.

Engineering of affibody molecules for therapy and diagnostics.

Joachim Feldwisch, Vladimir Tolmachev, J. Feldwisch, 2012, Methods in molecular biology.

Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use

Keith Paulsen, Jason R. Gunn, Brian W. Pogue, 2017, Molecular Imaging and Biology.

Update: affibody molecules for molecular imaging and therapy for cancer.

Joachim Feldwisch, Vladimir Tolmachev, L. Abrahmsén, 2007, Cancer biotherapy & radiopharmaceuticals.

Design of an optimized scaffold for affibody molecules.

Joachim Feldwisch, Vladimir Tolmachev, Anna Sjöberg, 2010, Journal of molecular biology.

Simultaneous In Vivo Fluorescent Markers for Perfusion, Protoporphyrin Metabolism, and EGFR Expression for Optically Guided Identification of Orthotopic Glioma

Linton T. Evans, Scott C Davis, Brian W Pogue, 2016, Clinical Cancer Research.

Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions

Brian W. Pogue, Keith D. Paulsen, Kimberley S. Samkoe, 2016, Molecular Imaging and Biology.

Preclinical imaging of epidermal growth factor receptor with ABY‐029 in soft‐tissue sarcoma for fluorescence‐guided surgery and tumor detection

Brian W Pogue, Keith D Paulsen, Joachim Feldwisch, 2019, Journal of surgical oncology.

Vision 20/20: Molecular-guided surgical oncology based upon tumor metabolism or immunologic phenotype: Technological pathways for point of care imaging and intervention.

Tayyaba Hasan, Brian W Pogue, Keith D Paulsen, 2016, Medical physics.

Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine

Joachim Feldwisch, Vladimir Tolmachev, L. Dinkelborg, 2009, Journal of Nuclear Medicine.